Roche in part-sale of mixed bag lebrikizumab to Dermira
California dermatology biotech Dermira will take on exclusive worldwide rights to IL-13 monoclonal antibody lebrikizumab from Roche, although the Big…
Roche pens $1B deal for respiratory bispecific from China
Roche has headed back to China to pen a licensing deal worth more than $1 billion biobucks for…
Does Big Pharma Deserve All the Hate?
This piece is the first in a series exploring the foundational players in the U.S. healthcare system: payers,…
Swiss Windward Bio adds US$165m to its Chinese pipeline
Basel-based Windward Bio has raised $165 million to advance a pipeline of long-acting immunology therapies—much of it sourced…
Alps Group Inc Announces Potential Pipeline Expansion
KUALA LUMPUR, Malaysia, Jan. 30, 2026 (GLOBE NEWSWIRE) — Alps Group Inc (the “Company” or “Alps Group”), the…
Something of a shopping spree: Novartis to acquire US-based Excellergy for up to $2bn
The life of a biotech company can be short—and if it appears on the fast-spinning takeover radar of…